Predemtec is a biotechnology company based in Germany that is setting new standards in Alzheimer's Diagnostics. The company was founded in 2011 and has developed a blood test for the accurate diagnosis of Alzheimer's disease.
The company's innovative approach to diagnosing Alzheimer's disease has garnered attention from investors, with their last investment being a Seed Round investment on 31 July 2014. This round of investment was led by HTGF | High-Tech Gruenderfonds, a prominent venture capital firm.
With its focus on cutting-edge technology and healthcare, Predemtec presents an intriguing opportunity for investors looking to support advancements in the biotechnology and healthcare industries.